Vizzutti F, Rega L, Arena U, Giulio RR, Meucci F, Barletta G, Schepis F, Tsalouchos A, Laffi G, Marra F

Idioma: Ingles.
Referencias bibliográficas: 13
Paginas: 127-131
Archivo PDF: 154.73 Kb.

RESUMEN

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. García-Pagán JC, Caca K, Bureau C, Laleman W, Appenrodt B, Luca A, Abraldes JG, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med 2010; 24: 2370-9.

2. Salerno F, Cammŕ C, Enea M, Rössle M, Wong F. Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data. Gastroenterology 2007; 133: 825-34.

3. Rossle M. TIPS: 25 years later. J Hepatol 2013; 59: 1081-93.

4. Azoulay D, Castaing D, Dennison A, Martino W, Eyraud D, Bismuth H. Transjugular intrahepatic portosystemic shunt worsens the hyperdynamic circulatory state of the cirrhotic patient: preliminary report of a prospective study. Hepatology 1994; 19: 129-32.

5. der Linden P Van, Le Moine O, Ghysels M, Ortinez M, Deviere J. Pulmonary hypertension after transjugular intrahepatic portosystemic shunt: effects on right ventricular function. Hepatology 1996; 23: 982-7.

6. Homma S, Sacco RL. Patent foramen ovale and stroke. Circulation 2005; 16: 1063-72.

7. Seib GA. Incidences of the patent foramen ovale cordis in adult American whites and American Negroes. Am J Anat 1934; 55: 511-25.

8. Tuennemann J, Mossner J, Hoffmeister A. Acute cerebrovascular incident as a complication of TIPS procedure. Z Gastroenterol 2013; 51: 381-3.

9. Appenrodt B, Schepke M, Kuntz-Hehner S, Schmiedel A, Sauerbruch T. A patient with portal hypertension and blindness after transjugular intrahepatic portosystemic shunt. Eur J Gastroenterol Hepatol 2006; 18: 447-9.

10. Lam YY, Yu CM, Zhang Q, Yan BP, Yip GW. Enhanced detection of patent foramen ovale by systematic transthoracic saline contrast echocardiography. Int J Cardiol 2011; 152: 24-7.

11. Braun M, Gliech V, Boscheri A, Schoen S, Gahn G, Reichmann H, Haass M, et al. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism. Periprocedural safety and mid-term follow-up results of three different device occlude systems. Eur H J 2004; 25: 424-30.

12. Meier B, Kalesan B, Mattle HP, Khattab AA, Hildick-Smith D, Dudek D, Andersen G, et al. Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med 2013; 368: 1083-91.

13. Carroll JD, Saver JL, Thaler DE, Smalling RW, Berry S, Mac- Donald LA, Marks DS, et al. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med 2013; 368: 1092-100.